Thus, based on the above hypothesis and questions, we developed a DCM model in vivo and in vitro to broaden our understanding of the role of lncRNA H19/miRNA-29c/MAPK in the function of melatonin in alleviating cardiomyocyte apoptosis. This evidence concerns the gene H19 and familial dilated cardiomyopathy.